Yale’s Post ASH Review

Target Audience

Specialties - Oncology

Overview

This meeting will recap the major takeaways from ASH through a program designed for hematologists involved in the treatment of patients with blood cancer.

Keynote Speaker: Marco Ruella, MD, Associate Professor of Medicine, Division of Hematology and Oncology and Center for Cellular Immunotherapies; Scientific Director, Lymphoma Program; Principal Investigator, Center for Cellular Immunotherapies; Director, CART Program, Penn Global Medicine University of Pennsylvania

Objectives

1. Describe the current treatment options and updates in various lymphoma, multiple myeloma, leukemia, and myeloid malignancies.
2. Discuss the development and outcomes of clinical research trials, cellular therapies, and transplant options for hematological malignancies and assess their relevance to patient care
3. Assess the emerging role of immunotherapy, targeted therapies, cellular therapies and antibodies in hematological malignancies
4. Review updates in classical hematology, including bleeding disorders and thrombosis

Registration

Registration is complimentary; however, we require you to register to account for seating and meals.

If you have any questions, please contact the Center for Continuing Medical Education at cme@yale.edu.